companies > G > Glenmark Pharma Glenmark Pharmaceuticals Glenmark acquires 7 pharmaceutical brands in Poland 02 July 2008 Glenmark gets USFDA approval for anti-hypertensive, Trandolapril 20 June 2008 Glenmark gets nod for marketing two drugs in US 30 May 2008 Glenmark's Swiss arm completes Phase I trials for monoclonal antibody GBR 500 10 April 2008 Glenmark Pharmaceuticals launches Clobetasol from its niche dermatology pipeline 17 March 2008 Glenmark receives milestone payment from Forest Labs for phase II study on Oglemilat 06 February 2008 US FDA approves Glenmark Pharmaceuticals Baddi semi-solids plant 28 January 2008 WHO grants international non-proprietary name Melogliptin to Glenmark Pharmaceuticals's anti-diabetic drug 14 January 2008 Glenmark Pharma to spin off generics unit, list new unit next year 17 November 2007 Glenmark signs up marketing deal with MyerZall Labs 27 October 2007 Glenmark and MeyerZall Laboratories to offers topical dermatology products in South Africa 25 October 2007 Glenmark Pharmaceuticals to market epilepsy drug oxcarbazepine in the US 10 October 2007 Glenmark acquires rights to two therapeutic antibodies from Chromos 19 July 2007 Glenmark receives US FDA approval for cardiac and NSAIDs generics 16 May 2007 Glenmark confirms filing ANDA with ''paragraph IV certification'' for Zetia tablets 28 March 2007 Glenmark acquires Czech firm Medicamanta 26 March 2007 Glenmark in funded research agreement with Swiss firm Dyax 12 March 2007 Merck pays Glenmark Rs148 crore upfront for diabetes drug 19 December 2006 Glenmark to start clinical trials of painkiller in Europe 14 December 2006 Glenmark signs an additional deal for seven ANDAs with LVT 07 December 2006 Glenmark develops API for Napo''s phase III diarrhoea drug trials by US 17 November 2006 Glenmark gets DCGI nod for Phase II trials of diarrhoea drug 03 August 2006 Glenmark, Merck''s Generics in derma products pact in the UK 17 July 2006 Paul Royalty to finance drug development by Glenmark 05 June 2006 Glenmark, is India''s first pharma company to implement ''structured product labeling'' 31 March 2006 Glenmark Pharmaceuticals announces new drug discovery for obesity 13 February 2006 Glenmark Pharmaceuticals Clinical Research unit in India receives ANVISA approval 08 February 2006 Glenmark Pharmaceuticals acquires Bouwer Bartlett, South Africa 26 December 2005 Glenmark Pharmaceuticals, InvaGen Pharmaceuticals in marketing tie-up 15 December 2005 Glenmark Pharmaceuticals targets GPs 10 October 2005 Glenmark acquires another brand in Brazil 18 March 2005 Glenmark Pharmaceuticals plans major foray into US markets 08 October 2003 Elder, Ajanta, Glenmark may buy known therapeutic brands 11 April 2003 Glenmark Pharmaceuticals to divest subsidiary for Rs 35 crore 10 February 2003  search domain-b    go
Legal Policy | Copyright © 1999-2008 The Information Company Private Limited. All rights reserved.